Results

eNauka >  Results >  Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study
Title: Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study
Authors: Fiala, Ondrej; ...; Popovic, Lazar S  ; ...; (broj, koautora 92)
Issue Date: 2023
Publication: CANCER IMMUNOLOGY IMMUNOTHERAPY
ISSN: 0340-7004 Cancer Immunology Immunotherapy Search Idenfier
Publisher: Springer
Type: Article
Collation: vol. 72 br. 11 str. 3665-3682
DOI 10.1007/s00262-023-03518-z.
WoS-ID: 001066059400001
Scopus-ID: 2-s2.0-85169897836
PMID: 37676282
PMCID: PMC10992198
URI: https://enauka.gov.rs/handle/123456789/935676
Project: The authors would like to thank all patients voluntarily taking part in the study.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21M21

23
SCOPUSTM
17
PubMed CentralTM
23
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.